Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events

scientific article published on 01 September 2002

Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1045723822
P356DOI10.1046/J.1523-1755.2002.00504.X
P698PubMed publication ID12164877

P50authorMatthias GirndtQ37381895
P2093author name stringChristof Ulrich
Martina Sester
Urban Sester
Hans Köhler
Harald Kaul
Thomas Georg
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectinterleukinsQ194908
P304page(s)949-955
P577publication date2002-09-01
P1433published inKidney InternationalQ6404823
P1476titleAnti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events
P478volume62

Reverse relations

cites work (P2860)
Q34808918A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients
Q54678857Altered CD46-mediated T cell co-stimulation in haemodialysis patients.
Q38816561C-reactive protein variability is associated with vascular access outcome in hemodialysis patients.
Q35847012Candidate Gene Analysis of Mortality in Dialysis Patients
Q37065637Candidate gene analysis of arteriovenous fistula failure in hemodialysis patients
Q35715691Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.
Q45165519Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress
Q34535945Electrolyzed-reduced water reduced hemodialysis-induced erythrocyte impairment in end-stage renal disease patients
Q61928029End-stage renal disease: a state of chronic inflammation and hyperleptinemia
Q34103416Evidence for anti-inflammatory effects of exercise in CKD.
Q37032679Genetic Considerations in Pediatric Chronic Kidney Disease.
Q38090908Immune cell dysfunction and inflammation in end-stage renal disease
Q36388062Inflammation markers predicting frailty and mortality in the elderly.
Q37848040Monitoring of inflammation in patients on dialysis: forewarned is forearmed
Q33919479Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice.
Q63684387Patogénesis de la malnutrición en pacientes en diálisis con énfasis en los aspectos más específicos de la diálisis peritoneal
Q36642091Place of genotyping and phenotyping in understanding and potentially modifying outcomes in peritoneal dialysis patients
Q36314913Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery
Q73392047Pneumococcal Septic Shock Is Associated with the Interleukin-10–1082 Gene Promoter Polymorphism
Q39277770Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients
Q91682629Regulatory T-cells and their impacts on cytokine profile of end-stage renal disease patients suffering from systemic lupus erythematosus
Q33835698The relationship between IL-10 levels and cardiovascular events in patients with CKD.
Q37119827Understanding the role of genetic polymorphisms in chronic kidney disease.
Q35106745Uremia-associated immune defect: The IL-10–CRP axis
Q35563082Uremic malnutrition-inflammation syndrome in chronic renal disease: a pathobiologic entity
Q30318078[Clinical issues with uremia].

Search more.